Dr. Jan Marie Bruder, MD

Dr. Bruder practices at University Hospital (San Antonio) in San Antonio, Texas.

Dr. Bruder's NPI, 1407963473, was assigned on August 24, 2006. Dr. Bruder graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1986. Dr. Bruder holds Texas license K1784.

Dr. Bruder's primary practice is University Hospital (San Antonio), at 4502 Medical Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 358-4000.

Dr. Bruder's primary practice is University Hospital (San Antonio) in San Antonio, Texas. Dr. Bruder is also affiliated with University Hospital. The medical group on file is UT Health Physicians. Dmand AI also links Dr. Bruder to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bruder practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Bruder's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Bruder is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Bruder's licenses on file in 3 states: Texas, Louisiana and Colorado.

Dmand AI lists hypercalcemia, osteoporosis, overactive thyroid, parathyroid gland disorder and underactive thyroid among the conditions Dr. Bruder treats.

CMS data shows 31 Medicare services from Dr. Bruder across 2 procedure codes in 2024, for 20 Medicare patients. Medicare paid $2,842 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 20 Medicare patients who saw Dr. Bruder in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bruder's median patient age at 66, with 55% women.

In 2024, Dr. Bruder wrote 46 Medicare Part D claims for 25 patients. 72% of them were for generic drugs. CMS names the drug for 23 of them, across 1 drug with 11 or more claims each, at $139 in total drug cost. In 2023, CMS named 191 claims across 5 drugs.

Dr. Bruder accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 53 papers to Dr. Bruder, published from 2005 to 2022. 2021 was the busiest year, with 5. The most frequent topics are Bone Density, Cell Line and Gonadotropin-Releasing Hormone. Dr. Bruder has published most often in J Clin Endocrinol Metab. Dr. Bruder's most frequent co-authors are Richard Lee Bauer, MD, Neil Aronin, MD and Joseph W. Basler, MD.

CMS Open Payments shows 7 general payments to Dr. Bruder from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Neurocrine BioSciences, Inc. paid the most, $134.

Dmand AI lists 3 awards for Dr. Bruder, most recently CMS Stage 1 EHR in 2013.

Dr. Bruder graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1986. Dr. Bruder is a member of ENDO.

Dr. Bruder is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.